Hospira Vinorelbine Tartrate for Injection 50 mg/5 mL vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

vinorelbine tartrate, Quantity: 13.85 mg/mL

可用日期:

Hospira Australia Pty Ltd

INN（国际名称）:

Vinorelbine tartrate

药物剂型:

Injection

组成:

Excipient Ingredients: water for injections

给药途径:

Intravenous

每包单位数:

1 x 5 mL vial

类:

Medicine Listed (Export Only)

处方类型:

Not scheduled. Not considered by committee

疗效迹象:

Vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (NSCLC), as a single agent or in combination. Vinorelbine tartrate is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. In addition, vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

產品總結:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

授权状态:

Licence status A

授权日期:

2008-05-05